Human Genome Epidemiology Literature Finder
|
Records 1 - 3 (of 3 Records) |
| Query Trace: Hepatitis A and CYP2C9[original query] |
|---|
| Genetic polymorphisms of drug-metabolizing enzymes and anti-TB drug-induced hepatitis. Pharmacogenomics 2009 Nov 10 (11): 1767-79. Kim Sang-Heon, Kim Sang-Hoon, Bahn Joon-Woo, Kim Yoon-Keun, Chang Yoon-Seok, Shin Eun-Soon, Kim Youn-Seup, Park Jae-Seuk, Kim Bo-Hyung, Jang In-Jin, Song Junghan, Kim Seung-Hyun, Park Hae-Sim, Min Kyung-Up, Jee Young-K |
| NAT2, CYP2C9, CYP2C19, and CYP2E1 genetic polymorphisms in anti-TB drug-induced maculopapular eruption. European journal of clinical pharmacology 2011 Feb 67 (2): 121-7. Kim Sang-Heon, Kim Sang-Hoon, Yoon Ho Joo, Shin Dong Ho, Park Sung Soo, Kim Youn-Seup, Park Jae-Seuk, Jee Young K |
| Effects of a Fixed-Dose Co-Formulation of Daclatasvir, Asunaprevir, and Beclabuvir on the Pharmacokinetics of a Cocktail of Cytochrome P450 and Drug Transporter Substrates in Healthy Subjects. Drugs in R&D 2017 12 18 (1): 55-65. Garimella Tushar, Tao Xiaolu, Sims Karen, Chang Yi-Ting, Rana Jignasa, Myers Elsa, Wind-Rotolo Megan, Bhatnagar Rahul, Eley Timothy, LaCreta Frank, AbuTarif Mal |
- Page last reviewed:Feb 1, 2024
- Content source: